HealthEquity, Inc.
HQY · NASDAQ
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,199,774 | $999,587 | $861,748 | $756,556 |
| % Growth | 20% | 16% | 13.9% | – |
| Cost of Goods Sold | $422,515 | $376,950 | $371,657 | $332,850 |
| Gross Profit | $777,259 | $622,637 | $490,091 | $423,706 |
| % Margin | 64.8% | 62.3% | 56.9% | 56% |
| R&D Expenses | $239,513 | $218,811 | $193,375 | $157,364 |
| G&A Expenses | $132,260 | $103,656 | $95,628 | $84,379 |
| SG&A Expenses | $222,999 | $182,929 | $164,477 | $142,984 |
| Sales & Mktg Exp. | $90,739 | $79,273 | $68,849 | $58,605 |
| Other Operating Expenses | $152,413 | $0 | $94,586 | $82,791 |
| Operating Expenses | $614,925 | $504,280 | $452,438 | $383,139 |
| Operating Income | $162,334 | $128,134 | $38,924 | $34,636 |
| % Margin | 13.5% | 12.8% | 4.5% | 4.6% |
| Other Income/Exp. Net | -$46,300 | -$53,094 | -$47,153 | -$42,503 |
| Pre-Tax Income | $116,034 | $75,040 | -$38,096 | -$66,741 |
| Tax Expense | $19,331 | $19,328 | -$11,953 | -$22,452 |
| Net Income | $96,703 | $55,712 | -$26,143 | -$44,289 |
| % Margin | 8.1% | 5.6% | -3% | -5.9% |
| EPS | 1.11 | 0.65 | -0.31 | -0.53 |
| % Growth | 70.8% | 309.7% | 41.5% | – |
| EPS Diluted | 1.09 | 0.64 | -0.31 | -0.53 |
| Weighted Avg Shares Out | 86,870 | 85,564 | 84,442 | 83,133 |
| Weighted Avg Shares Out Dil | 88,828 | 86,957 | 84,442 | 83,133 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13,914 | $12,138 | $1,763 | $1,501 |
| Interest Expense | $60,634 | $55,455 | $48,424 | $36,572 |
| Depreciation & Amortization | $162,451 | $153,078 | $161,201 | $137,188 |
| EBITDA | $337,543 | $282,416 | $171,529 | $102,970 |
| % Margin | 28.1% | 28.3% | 19.9% | 13.6% |